RTTNews | Feb 23, 2021 07:17AM EST

07:16 Tuesday, February 23, 2021 (RTTNews) - RedHill Biopharma Plans To Expand Phase 2/3 Study Of Opaganib In Patients With Severe COVID-19 To The U.S.

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved